348 results
Page 8 of 18
8-K
EX-2.1
gs9 1j512
18 Jun 12
NeoStem Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye
12:00am
CORRESP
wr783
15 Jun 12
Correspondence with SEC
12:00am
8-K
EX-4.1
ih1 r25j25
29 Mar 12
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
12:00am
8-K
mp7bbkh2ylp0rb
29 Mar 12
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
12:00am
8-K
EX-99.1
0d3dg0b5307w7
29 Mar 12
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
12:00am
424B5
nbfhnjtl
29 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
vx6s3za53ti 8v51q
29 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
g2cllzmi
29 Mar 12
NeoStem Announces Pricing of Public Offering for $6,000,000 in Gross Proceeds
12:00am
8-K
EX-99.1
8bg43vwdm6s
20 Mar 12
NeoStem Provides Updates and Reports Year End Results
12:00am
8-K
EX-99.3
5scb60pbnx6tei3457
6 Jan 12
NeoStem, Inc. (“NBS”) Investor Presentation January 2012
12:00am
8-K
EX-10.2
um3w769 xs
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
EX-4.1
x0fg3 c4ezmg
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
EX-10.3
r71x3b
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
sy1xmwwty1v mf5sclc
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
EX-10.1
0tc184730z x7xe
30 Sep 11
Entry into a Material Definitive Agreement
12:00am